logo

For the Inventor, By the Inventor

Boulder, CO, United States of America

Bolder Biotechnology, Inc.


USPTO Granted Patents = 45



Forward Citations = 753

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal George N Cox (45 out of 58 patents)

silverMedal Mary S Rosendahl (9 out of 18 patents)

bronzeMedal Daniel H Doherty (9 out of 27 patents)

4.  Christie M Orschell (5 out of 5 patents)

5.  Meetha Manek Medhora (2 out of 2 patents)

6.  Brian Fish (2 out of 2 patents)

7.  Daniel J Doherty (1 out of 1 patent)

8.  George N Iii Cox (0 patent)


Core Competencies:
Hematopoietic Growth Factor
Cysteine Variants
Interleukin-11
Granulocyte Colony Stimulating Factor
PEGylated Proteins
Beta Interferon
VEGF Inhibitors
Erythropoietin
Immunoglobulin Fusion Proteins
Growth Hormone Supergene Family
Cysteine Muteins
Radiation Exposure Treatment

45 patents:

1. 12274736 - Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure (2025-04-14),
2. 11229683 - Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure (2022-01-25),
3. 10653752 - Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure (2020-05-19),
4. 10508131 - Cysteine analogs of exendin-4 (2019-12-17),
5. 10329337 - Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11 (2019-06-25),
6. 10016485 - Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure (2018-07-10),
7. 9637530 - Methods of preparing cysteine variants of human recombinant IL-11 (2017-05-02),
8. 9320777 - Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure (2016-04-26),
9. 9296804 - NH2-terminal glutamine modified cysteine variants of interferon gamma (2016-03-29),
10. 8957023 - Methods for making proteins containing free cysteine residues (2015-02-17),
11. 8932828 - Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins (2015-01-13),
12. 8859497 - Method of treatment using cysteine mutants of beta interferon (2014-10-14),
13. 8748392 - Methods of treatment using cysteine variants of interleukin-11 (2014-06-10),
14. 8618256 - Cysteine variants of interferon gamma (2013-12-31),
15. 8617531 - Methods of making proteins and peptides containing a single free cysteine (2013-12-31),
Bolder Biotechnology, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative protein-based therapeutics. We specialize in developing proprietary protein therapeutics with enhanced properties for the treatment of various diseases. Our advanced technologies and expertise allow us to create novel drugs that have the potential to significantly impact patient outcomes. Visit our website to learn more about our groundbreaking research and product pipeline.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

45 Patents

#29 in Boulder, CO

#141 in Colorado

#7,502 in US

#14,991 in the World

...
Boulder, CO, United States of America

Bolder Biotechnology, Inc.

Forward Citations = 753

7 inventors:

goldMedal George N Cox (45 out of 58 patents)

silverMedal Mary S Rosendahl (9 out of 18 patents)

bronzeMedal Daniel H Doherty (9 out of 27 patents)

4.  Christie M Orschell (5 out of 5 patents)

5.  Meetha Manek Medhora (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com
Loading…